Authors: A. Mareček Published in: Listy rev. Lék., 10, 2006, č. 1, s. 13-14
Covering the treatment of a child affected by the autosomal recessive immunodeficiency of the ADA enzyme from the funds of public health insurance.
Key words: immunodeficiency of the ADA enzyme – unique haplotype – substitution of the PEG ADA enzyme – genic therapy
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
